Mutational and Epigenetic Mechanisms of Susceptibility and Risks
for Genetic Diseases
| Saturday, October 20, 2007 |
| 7:00 AM–10:30 AM |
Dunwoody Foyer |
| |
Registration |
|
| 8:00 AM–12:00 Noon |
Dunwoody Room |
| |
Saturday Workshop: On-Going Initiatives in Genetic Toxicology
Testing and Risk Assessment
(Separate Registration Required)
Several regulatory and multi-stakeholder initiatives are currently
underway at regional and international levels to update the genetic
toxicology testing paradigm in order to enhance its utility for hazard
and risk assessment. These initiatives include identification of
strategies to follow-up on findings from the initial battery of in vitro tests, developing a weight of evidence approach for evaluating
genotoxicity data, and the incorporation of animal alternative
considerations (refine, reduce, and replace animal usage) in selecting
and designing genetic toxicology studies. This workshop will provide a
forum for discussing these new initiatives and how they might impact the
field of genetic toxicology. The workshop will benefit not only those in
industrial and regulatory settings, but also a cross-section of EMS
membership by providing an update on new approaches and guidelines in
genetic toxicology assessment. |
Chairpersons: Véronique T. Thybaud, Sanofi-aventis, France
and Bhaskar Gollapudi, The Dow Chemical Company
Sponsored by Covance Laboratories Ltd. UK,
ILSI-HESI, Mitsubishi Pharma, Sanofi-aventis,
and The Dow Chemical Company |
| 8:00 AM–8:05 AM |
| |
Introduction |
|
| 8:05 AM–8:35 AM |
| |
Choice of In Vivo Follow-up Testing in Case of In
Vitro Positive Findings |
Speaker: David Kirkland, Covance Laboratories Ltd. UK |
| 8:35 AM–9:00 AM |
| |
In Vivo Comet Assay: Update on the On-Going Validation Coordinated
by JaCVAM |
Speaker: Yoshifumi Uno, Mitsubishi Pharma Corporation, Japan |
| 9:00 AM–9:30 AM |
| |
Relevance and Follow-up of Positive Results in In Vitro Genetic Toxicity
Assays: An ILSI-HESI Initiative |
Speaker: Bhaskar Gollapudi, The Dow Chemical Company |
| 9:30 AM–10:00 AM |
| |
Update on the Maintenance of the ICH S2 Genetic Toxicology
Guidelines |
Speaker: Makoto Hayashi, National Institute of Health Sciences, Japan |
| 10:00 AM–10:15 AM |
| |
Break |
|
| 10:15 AM–10:45 AM |
| |
Application of 3R’ Principle on Genetic Toxicology Evaluation:
European Position for Cosmetics and Chemicals |
Speaker: Raffaela Corvi, ECVAM, Italy |
| 10:45 AM–11:15 AM |
| |
Application of 3R’ Principle on Genetic Toxicology Evaluation:
Impact on Industry and On-Going Initiatives |
Speaker: Marilyn Aardema, The Procter & Gamble Company |
| 11:15 AM–11:45 AM |
| |
Use of Weight of Evidence and Mode of Action Approaches in Genetic
Toxicology Risk Assessment |
Speaker: Rita Schoeny, U.S. Environmental Protection Agency |
| 11:45 AM–12:00 Noon |
| |
Conclusion—Perspectives: Other On-Going Initiatives
and Guideline Revisions |
Speaker: Véronique Thybaud, Sanofi-aventis, France |
|
| 11:00 AM–6:00 PM |
Centennial III Foyer |
| |
Registration |
|
| 12:00 Noon–2:00 PM |
Fairlie Room |
| |
Executive Board Meeting |
|
| 12:00 Noon–4:30 PM |
Centennial II Ballroom |
| |
Saturday Workshop: Predicting Chemical Carcinogenicity, Moving
Beyond Batteries
(Separate Registration Required)
This workshop will present initial results from the ad hoc Working Group on Predicting
Chemical Carcinogenicity and provide a forum for discussion. This ad hoc group is seeking to
better identify the mechanisms of carcinogenicity, how these can be understood theoretically, and how they can
be measured. The group seeks to determine whether application of greater understanding of biology and new
tools, such as toxicogenomics, might improve assessment of carcinogenicity of chemicals. This workshop will present
initial ideas and concepts on accelerated hazard identification. The group hopes to ultimately build support for improved methods that can support
policy decisions.
The workshop objectives are:
- To discuss key developments in the understanding of cancer biology and their implications.
- To review progress to date by the Working Group on Predictive Carcinogenesis on the identification
of modes of action for carcinogenesis and gain feedback.
|
Chairpersons: Martyn T. Smith, University of California–Berkeley
and Michael D. Waters, Integrated Laboratory Systems, Inc
Sponsored by U.S. Environmental Protection Agency, ILS, Inc., and Pfizer Inc. |
| 12:00 Noon–12:15 PM |
| |
Meeting Check In
(lunch available for registered participants) |
|
| 12:15 PM–12:30 PM |
| |
Welcome and Review of Workshop Objectives |
Speaker: Martyn T. Smith, University of California, Berkeley |
| 12:30 PM–12:45 PM |
| |
Introduction of Participants |
|
| 12:45 PM–12:55 PM |
| |
Approach of the Working Group: Overview |
Speaker: Michael D. Waters, Integrated Laboratory Systems, Inc. |
| 12:55 PM–1:15 PM |
| |
Where Have We Been and Where Do We Want To Go: Motivations for Change |
Speakers: Bob Sonawane, U.S. Environmental Protection Agency, Office
of Research and Development; and Vincent J. Cogliano, International Agency for Research
on Cancer |
| 1.15 PM–1:45 PM |
| |
Where Are We Now: Presentation of Mechanisms for Carcinogenesis and Critical Issues in Distinguishing Between Them |
Speakers: David Eastmond, University of California,
Riverside; Nagu Keshava, U.S. Environmental Protection Agency and Martha
Sandy, California Environmental Protection Agency |
| 1:45 PM–1:55 PM |
| |
Questions and Discussion
|
|
| 1:55 PM–2:20 PM |
| |
Impact of Recent Breakthroughs in Cancer Biology |
Speaker: Martyn T. Smith, University of California, Berkeley |
| 2:20 PM–2:40 PM |
| |
Break |
|
| |
| |
Where Should We Go and What Do We Do Next? |
Chairperson: Michael Waters, Integrated Laboratory Systems, Inc. |
| 2:40 PM–2:55 PM |
| |
Predicting Animal Carcinogenicity |
Speaker: Michael Waters, Integrated Laboratory Systems Inc. |
| 2:55 PM–3:10 PM |
| |
In Vitro Tests to Predict Cancer |
Speaker: Jiri Aubrecht, Pfizer Inc. |
| 3:10 PM–3:25 PM |
| |
Biomarkers of Cancer Risk in Humans |
Speaker: Luoping Zhang, University of California, Berkeley |
| 3:25 PM–3:40 PM |
| |
Discussion |
|
| 3:40 PM–4:10 PM |
| |
Future Directions: Implications for Research, Risk Assessment, and
Public Policy
|
Speakers: Amy D. Kyle, University of California, Berkeley; and Kate Guyton, U.S. Environmental Protection Agency |
| 4:10 PM–4:20 PM |
| |
Comments from Participants |
|
| 4:20 PM–4:30 PM |
| |
Closing Comments |
Chairpersons: Martyn T. Smith, University of California, Berkeley
and Michael D. Waters, Integrated Laboratory Systems, Inc. |
|
| 1:30 PM –4:30 PM |
Courtland Room |
| |
Young Investigator Workshop: Anatomy of a Successful Grant
Application and a Research Project
(Separate Registration Required)
This educational session is designed to help the young investigator think
about the whole grant writing process. Questions to be addressed in this
workshop include: Do you have research or an idea worthy of a grant? How
much preliminary data is needed? How much money do I ask for? What are
NIH requirements? What does a study section really look for in a grant?
How do I make my grant stand out from the competition? Do young investigators
have a chance in the competition? How much of the work can I complete and
still ask for a grant to fund it? And more. |
Chairpersons: James S. Felton, Lawrence Livermore National Laboratory
and Meredith Crosby, Yale University |
| 1:30 PM–2:15 PM |
| |
Grant Application Writing Experience From a Veteran Who Has Won and Lost |
Speaker: James S. Felton, Lawrence Livermore National Laboratory |
| 2:15 PM–3:00 PM |
| |
Experiences of a Young Investigator |
Speaker: Meredith Crosby, Yale University |
| 3:00 PM–3:45 PM |
| |
NIH Extramural Grants Administrator |
Speaker: Elizabeth G. Snyderwine, National Cancer Institute |
| 3:45 PM–4:30 PM |
| |
Professional Grant Application Writer |
Speaker: To be announced |
|
| 2:30 PM–4:30 PM |
Baker Room |
| |
EMS Council Meeting |
|
| 4:30 PM–7:00 PM |
Centennial I Ballroom |
| |
Student and Postdoctoral Fellow Poster Session, Job Fair, and Welcome Reception
The Student and New Investigator Poster Session and Welcome Reception
will highlight the research of students and new investigators and provide
them with an extra opportunity to present and discuss their research. Alongside
with the poster session, we will run a Job Fair, highlighting the opportunities
that exist in the university and government labs. The concurrent job fair
and poster session will allow the students and new investigators to present
their research work to potential employers. The esteemed Education and
Student Affairs Committee Award will be presented during this session in
recognition for dedication to student activities.
This session will provide an opportunity for students and new or postdoctoral
investigators to present their data to the meeting attendees prior to their
formal presentation later in the week. This event is also a great time
to become reacquainted with your colleagues before the meeting. |
Co-Sponsored by Amgen,
Inc. |
|